Medennium Inc.
This article was originally published in Start Up
Executive Summary
Phakic intraocular lenses may offer solutions for patients that suffer from high degrees of myopia or hyperopia, Medennium Inc. 's PRL, in phase II clinical trials, is a posterior phakic intraocular lens.